about
Effect of a small molecule Lipid II binder on bacterial cell wall stress.Finding Novel Antibiotic Substances from Medicinal Plants - Antimicrobial Properties of Nigella Sativa Directed against Multidrug-resistant Bacteria.Bacterial proteases, untapped antimicrobial drug targets.Determination of Disk Diffusion and MIC Quality Control Guidelines for High Dose Cefepime-Tazobactam (WCK 4282), a Novel Antibacterial Combination Consisting of a β-Lactamase Inhibitor and a Fourth-Generation Cephalosporin.ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii.WCK 5222 (cefepime/zidebactam) antimicrobial activity tested against Gram-negative organisms producing clinically relevant β-lactamases.Secretory Products of the Human GI Tract Microbiome and Their Potential Impact on Alzheimer's Disease (AD): Detection of Lipopolysaccharide (LPS) in AD Hippocampus.Kinetics of Sulbactam Hydrolysis by β-Lactamases, and Kinetics of β-Lactamase Inhibition by Sulbactam.Rational antibiotic design: in silico structural comparison of the functional cavities of penicillin-binding proteins and ß-lactamases.Regulation of Class A β-Lactamase CzoA by CzoR and IscR in Comamonas testosteroni S44.Mutual influence of secondary and key drug‐resistance mutations on catalytic properties and thermal stability of TEM‐type β‐lactamases.The frequency and mechanism of spontaneous resistance to sulbactam combined with the novel β-lactamase inhibitor ETX2514 in clinical isolates of Acinetobacter baumannii.Copper Ions and Coordination Complexes as Novel Carbapenem Adjuvants.13C-Carbamylation as a mechanistic probe for the inhibition of class D β-lactamases by avibactam and halide ions.[Antibiotic transport and membrane permeability: new insights to fight bacterial resistance].Multidrug-Resistant Escherichia albertii: Co-occurrence of β-Lactamase and MCR-1 Encoding Genes.in vitro Activity of Imipenem-Relebactam and Ceftolozane-Tazobactam Against Resistant Gram-Negative Bacilli.Defining substrate specificity in the CTX-M family: the role of Asp240 in ceftazidime hydrolysis.Empirical antimicrobial treatment in haemato-/oncological patients with neutropenic sepsis.Roles of 2-oxoglutarate oxygenases and isopenicillin N synthase in β-lactam biosynthesisDiversity and Proliferation of Metallo-β-Lactamases: a Clarion Call for Clinically Effective Metallo-β-Lactamase Inhibitors
P2860
Q37682911-6EE0DBCD-3E2B-431D-8C3E-43C639C980F6Q38848804-7DB4B1F6-317D-4C01-802C-E9B06648264BQ39023951-1D9652AC-D425-4803-98D0-604D52774F32Q40099704-057FB54A-F388-4817-8CE9-C34E0207A746Q40152356-65E85D23-7054-4CAF-A764-6F20B3260F61Q40281991-2ED0E805-DCE0-4923-B2D2-780DD4AB1696Q40978202-931F8409-94C2-4E19-A063-BDBCD1CDADB8Q46296415-03D46111-479A-477A-946C-13775602C2B2Q46772686-3948F843-0328-4DF9-8FF8-FDBF345890A7Q47192196-A8B82F65-8461-476D-B5AE-48368FF02948Q47312911-212B27AA-54F7-4A54-A88E-CA3F189C5F64Q47406932-C7D86A37-7290-40C9-AB47-50FF1F897515Q47709666-73A8514D-80A1-444D-A0BD-A574DF41FB58Q47983005-0D98BBB6-0497-4EA6-BD7D-6A1F6D8C1032Q50148090-56CD7A25-3A9C-4F65-82D7-4EDA00EDD371Q52674855-DB8ED09C-2EC2-47A1-B98D-F59BC0806C5CQ53682525-1D361C2F-99AF-448C-936E-81C245A282FFQ53697061-74E6ADDF-198B-4978-A75E-FC15C3730E9FQ55308858-B5ED7E4E-BE7F-48C4-95FB-D0663F33B66BQ57808321-5BB16AA6-6E0B-4F74-93E3-F63FA95ACDB3Q58641878-FFFCA9DB-B46D-4EB8-867E-D93FEDC4A885
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
β-Lactams and β-Lactamase Inhibitors: An Overview.
@en
type
label
β-Lactams and β-Lactamase Inhibitors: An Overview.
@en
prefLabel
β-Lactams and β-Lactamase Inhibitors: An Overview.
@en
P2860
P1476
β-Lactams and β-Lactamase Inhibitors: An Overview.
@en
P2093
Karen Bush
P2860
P356
10.1101/CSHPERSPECT.A025247
P577
2016-06-21T00:00:00Z